Kinapse featured in the Fast Track 100 for third consecutive year
London (PRWEB UK) 10 December 2015 -- For the third consecutive year, Kinapse has been listed in the Sunday Times Fast Track 100 of the fastest growing companies registered in the UK. Kinapse was rated as number 89 in the list published on 7th December 2015.
Kinapse also celebrated its first appearance in the Sunday Times SME Export Track 100 this year.
Kinapse has been celebrating its 10th year in 2015 and has achieved several milestones:
•Passing 500 staff globally
•Quadrupling the size of its US team and expanding offices in Chicago, Cambridge and Manhattan
•Expanding operations and teams in Bangalore and Gurgaon, India
•Securing important contracts with nine of the top ten global pharmaceutical companies
•Extending and expanding its strategic partnership with the European Medicines Agency
•Achieving independent recognition of the achievements of senior executives including Suzanne Budsworth, Head of Operational Services as one of the UK’s top 50 senior executives working in a part-time capacity. Also Bob Clay, Kinapse Chief Regulatory Officer, and Aileen Fisher, Head of Regulatory Services, who were appointed to the Board of The Organisation of Professionals in Regulatory Affairs (TOPRA).
Commenting on another dynamic year for the business, Andy Black, Chief Executive Officer, said: “I am delighted by our global team’s great achievements this year. Being recognised in this prestigious listing for the third year running is something we should all be very proud of. In partnership with our clients and other partners, we have a built a business which has exceptional potential and we continue to see growth across our Advise-Build-Operate services accelerating today”.
To learn more about Kinapse’s Advise-Build-Operate approach please visit http://www.kinapse.com/we-are-10.
To find out more about this year’s Fast Track please visit http://www.fasttrack.co.uk.
For press enquiries, contact Amanda Swain at amanda.swain(at)kinapse(dot)com.
Amanda Swain, Kinapse, +44 2089467600, [email protected]
Share this article